Vivos Therapeutics (VVOS) Minority Interest (2025 - 2026)
Vivos Therapeutics' (VVOS) quarterly Minority Interest came in at -$129000.0 in Q1 2026, down 115.0% on a QoQ basis from -$60000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Minority Interest (2025 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 2 years of Minority Interest data on file, last reported at -$129000.0 in Q1 2026.
- On a quarterly basis, Minority Interest changed N/A year-over-year to -$129000.0 in Q1 2026; TTM through Mar 2026 was -$129000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$60000.0, changed N/A from the prior year.
- Minority Interest for Q1 2026 stood at -$129000.0, down from -$60000.0 in the prior quarter.
- Over the last five years, Minority Interest for VVOS reached as high as -$60000.0 in Q4 2025 and fell as low as -$129000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Vivos Therapeutics | 3.62 Mn | 1.38 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129,000.00 |
| Dec 31, 2025 | -60,000.00 |